What is Arcadia Biosciences?
Founded in 2002 and headquartered in Davis, California, Arcadia Biosciences is a pioneering agricultural biotechnology firm dedicated to the development and commercialization of high-value, sustainable agricultural products. The company leverages advanced genetic research to improve crop performance, enhance nutritional profiles, and promote environmental stewardship. By focusing on the intersection of science and agriculture, Arcadia Biosciences addresses critical global challenges such as food security and climate resilience. Its market position is defined by a portfolio of differentiated technologies that provide tangible benefits to both farmers and consumers, positioning the firm as a leader in the transition toward more efficient and sustainable food systems.
How much funding has Arcadia Biosciences raised?
Arcadia Biosciences has raised a total of $155.5M across 9 funding rounds:
Other Financing Round
$15M
Private Equity
$33M
Stock Offering
$65.6M
Share Placement
$25M
Multiple Rounds
$10.8M
Stock/Share Issuance
$2.1M
Stock/Share Issuance
$4M
Other Financing Round (2008): $15M with participation from CMEA Ventures, Exeter Life Sciences, Saints Capital, and BASF Venture Capital America Inc.
Private Equity (2014): $33M led by Mandala Capital, CMEA Ventures, BASF Venture Capital, and Saints Capital
Stock Issuance/Offering (2015): $65.6M, investors not publicly disclosed
Share Placement (2015): $25M featuring Silicon Valley Bank
Unspecified (2020): $3M, investors not publicly disclosed
Debt (2020): $1M with participation from PPP
Debt (2020): $6.8M led by Undisclosed
Stock/Share Issuance (2026): $2.1M, investors not publicly disclosed
Stock/Share Issuance (2026): $4M, investors not publicly disclosed
Key Investors in Arcadia Biosciences
CMEA Ventures
CMEA Capital is a San Francisco-based venture capital firm with a clear focus on life sciences, high technology, and energy and materials investments, targeting companies with highly differentiated technology.
Silicon Valley Bank
SVB Financial Group offers comprehensive commercial and private banking, asset management, and brokerage services, supporting the growth of innovative companies since 1983.
BASF Venture Capital
BASF Venture Capital GmbH is the corporate venture capital arm of the BASF Group, focusing on strategic investments in biotechnology, circular economy, and artificial intelligence to foster global innovation.
What's next for Arcadia Biosciences?
With the successful closure of this major enterprise-level funding, Arcadia Biosciences is poised to enter a new phase of operational expansion and market penetration. The strategic allocation of these funds will likely prioritize the scaling of its core biotechnology research and the broadening of its commercial distribution networks. As the company continues to refine its product offerings, the focus will remain on achieving operational milestones that drive long-term shareholder value and industry-wide impact. Investors and stakeholders will be closely monitoring the firm's ability to translate this capital into sustained growth, particularly as it navigates the evolving regulatory and competitive landscape of the global ag-tech market.
See full Arcadia Biosciences company page
